A macrolactone from benzo[a]phenazine with potent activity against Mycobacterium tuberculosis

European Journal of Medicinal Chemistry

Volumn 44, Issue 5, 2009, Pages 2334-2337

  Silva, Raphael S F ^a   Pinto, Maria do Carmo F R ^a   Goulart, Marília O F ^b   de Souza Filho, José D ^c   Neves Jr , Ivan ^d   Lourenço, Maria Cristina S ^d   Pinto, Antonio V ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Lapachol; Macrolactones; Peracetic acid oxidation; Phenazines; Tuberculosis

Indexed keywords

7,7 DIMETHYL 7,8 DIHYDROBENZO[3,4]OXONINO[6,7 B]QUINOXALINE 5,9 DIONE; LACTONE DERIVATIVE; PERACETIC ACID; PHENAZINE DERIVATIVE; QUINOXALINE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATION; OZONOLYSIS;

ANTITUBERCULAR AGENTS; LACTONES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXIDATION-REDUCTION; PHENAZINES; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 62549127268     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.06.014     Document Type: Article

References (19)

1. World Health Organization. Global Health Atlas (2006). (accessed July 2006)
2. World Health Organization Tuberculosis Fact Sheet No. 104 - Global and regional incidence, March 2006.
3. Shepp D.H., Tang I.T., Ramundo M.B., and Kaplan M.K. J. Acquir. ImmuneDefic. Syndr. 7 (1994) 823-883
4. F de Pinho A.M., Santoro-Lopes G., Harrison L.H., and Schechter M. AIDS 15 (2001) 2129-2135
5. Machado T.B., Pinto A.V., Pinto M.C.F.R., Leal I.R.C., Silva M.G., Amaral A.C.F., Kuster R.M., and Neto-dos Santos K.R. Int. J. Antimicrob. Agents 21 (2003) 279-284
6. de Moura K.C.G., Salomão K., Menna-Barreto R.F.S., Emery F.S., Pinto M.C.F.R., Pinto A.V., and de Castro S.L. Eur. J. Med. Chem. 39 (2004) 639-645
7. Pinto C.N., Malta V.R.S., Pinto M.C.F.R., Santos R.H.A., de Castro S.L., and Pinto A.V. J. Med. Chem. 45 (2002) 2112-2115
8. De Andrade-Neto V.F., Goulart M.O.F., Da Silva Filho J.F., Da Silva M.J., Pinto M.C.R., Pinto A.V., Zalis G.M., Carvalho L.H., and Krettli A.U. Bioorg. Med. Chem. Lett. 14 (2004)
9. Goulart M.O.F., Cioletti A.G., de Souza Filho J.D., De Simone C.A., Castellano E.E., Emery F.S., De Moura K.C.G., Pinto M.C.F.R., and Pinto A.V. Tetrahedron Lett. 44 (2003) 3581-3585
10. Silva R.S.F., Guimarães T.T., Teixeira D.V., Lobato A.P.G., Pinto M.C.F.R., de Simone C.A., Soares J.G., Cioletti A.G., Goulart M.O.F., and Pinto A.V. J. Braz. Chem. Soc. 16 (2005) 1074-1077
11. de Simone C.A., Silva R.P., Goulart M.O.F., Silva R.S.F., Lobato A.P.G., Pinto M.C.F.R., and Pinto A.V. J. Chem. Crystallogr. 36 (2006) 551-556
12. Hooker S.C. J. Am. Chem. Soc. 58 (1936) 1174-1176
13. Zarranz B., Jaso A., Aldana I., and Monge A. Bioorg. Med. Chem. 11 (2003) 2149-2156
14. Zanetti S., Sechi L.A., Molicotti P., Cannas S., Carta A., Bua A., Deriu A., and Paglietti G. Int. J. Antimicrob. Agents 25 (2005) 179-181
15. Kamal A., Babu A.H., Ramana A.V., Yadav R.S.J.S., and Arora S.K. Bioorg. Med. Chem. Lett. 15 (2005) 1923-1926
16. Navarrete-Vázquez G., Molina-Salinas G.M., Duarte-Fajardo Z.V., Vargas-Villarreal J., Estrada-Soto S., González-Salazar F., Hernández-Núñez E., and Said-Fernández S. Bioorg. Med. Chem. 15 (2007) 5502-5508
17. Silva R.S.F., de Amorim M.B., Pinto M.C.F.R., Emery F.S., Goulart M.O.F., and Pinto A.V. J. Braz. Chem. Soc. 18 (2007) 759
18. Collins L.A., and Franzblau S.G. Antimicrob. Agents Chemother. 41 (1997) 1004-1009
19. Franzblau S.G., Cook M.B., Quenzer V.K., Ferguson R.M., and Gilman R.H. J. Clin. Microbiol. 36 (1998) 362